Antibodies to SARS-CoV-2 in patients with primary immunodeficiencies treated with nonspecific immunoglobulins

Immunology. 2022 Aug;166(4):539-542. doi: 10.1111/imm.13495. Epub 2022 May 31.

Jorge Eguía^{1

2}, M Araceli Caballero-Rabasco^{2

3}, M Lourdes Cos^{2

4}, Santiago Grau⁵, Leonardo Mellibovsky^{2

4}, Eduardo Villegas^{1

2}, Fabiola Blasco^{4

6

7}, Ana Lemus^{4

6}, Marta Crespo⁸, Eduardo Padilla¹, Ramón Gimeno^{2

7

9

10}

¹ Laboratori de Referència de Catalunya SA, El Prat de Llobregat, Spain.
² Immunodeficiencies Unit, Hospital del Mar, Barcelona, Spain.
³ Department of Pediatrics, Hospital del Mar, Barcelona, Spain.
⁴ Department of Internal Medicine, Hospital del Mar, Barcelona, Spain.
⁵ Department of Pharmacy, Hospital del Mar, Barcelona, Spain.
⁶ Department of Infectious Diseases, Hospital del Mar, Barcelona, Spain.
⁷ Laboratory of Immunology, Department of Pathology, Hospital del Mar, Barcelona.
⁸ Department of Nephrology, Hospital del Mar, Barcelona, Spain.
⁹ Immunity and Infection, Hospital del Mar Medical Research Institute, Barcelona, Spain.
¹⁰ Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.

No abstract available

Publication types